(Q40802614)

23 September 2017

Sleep and the immune response (English)

1 reference

23 September 2017

Krueger JM

1

1 reference

PubMed ID

2440372

23 September 2017

Karnovsky ML

series ordinal

2

1 reference

PubMed ID

2440372

23 September 2017

language of work or name

English

0 references

publication date

1 January 1987

1 reference

Annals of the New York Academy of Sciences

23 September 2017

1 reference

23 September 2017

496

1 reference

23 September 2017

510-516

1 reference

Sleep-promoting effects of muramyl peptides.

23 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1987.TB35808.X

Differential sleep-promoting effects of five sleep substances nocturnally infused in unrestrained rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1987.TB35808.X

Characterization of a delta-electroencephalogram (-sleep)-inducing peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1987.TB35808.X

Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1987.TB35808.X

Muramyl peptides. Variation of somnogenic activity with structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1987.TB35808.X

The comparative effects of isoprinosine, levamisole, muramyl dipeptide and SM1213 on lymphocyte and macrophage proliferation and activation in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1987.TB35808.X

Direct augmentation of cytolytic activity of tumor-derived macrophages and macrophage cell lines by muramyl dipeptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1987.TB35808.X

The Pyrogenicity of the Synthetic Adjuvant Muramyl Dipeptide and Two Structural Analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1987.TB35808.X

Increased production of superoxide anion by macrophages exposed in vitro to muramyl dipeptide or lipopolysaccharide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1987.TB35808.X

Sleep factors: do muramyl peptides activate serotonin binding sites?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1987.TB35808.X

Muramyl peptides and serotonin interact at specific binding sites on macrophages and enhance superoxide release

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1987.TB35808.X

An update on human interleukin-1: from molecular biology to clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1987.TB35808.X

Effects of intracerebroventricular administration of prostaglandin D2 on behaviour, blood pressure and body temperature as compared to prostaglandins E2 and F2 alpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1987.TB35808.X

Stressor exposure and immunological response in man: interferon-producing capacity and phagocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1987.TB35808.X

Expression of major histocompatibility complex antigens in neonate rat primary mixed glial cultures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1987.TB35808.X

10.1111/J.1749-6632.1987.TB35808.X

21 January 2018

Identifiers

DOI

1 reference

23 September 2017

1 reference

PubMed ID

2440372